For how we live.
A modelling study of Koungou village, calibrated to daily cases by vaccination status, estimates CVD 103-HgR prevented 87% of cholera and averted hundreds of cases — a first real-world test of a challenge-trial vaccine.
A 2026 review reports more than 70 health facilities destroyed in North Kivu, 7.3 million people displaced and over 2 million children acutely malnourished, as conflict compounds overlapping outbreaks.
A vaccine given in 2017 still cut cholera risk 78% five years on, new data show — even as collapsing water and health services let the outbreak spread through Artibonite and Centre.
Severe dehydration from diarrhoeal disease and sepsis can shut down the kidneys. In a health system with little dialysis, a review argues this is a preventable driver of death that surveillance is missing.
WHO's latest tally puts the 2026 year-to-date count at 58,740 cases and 732 deaths across 22 countries, down sharply from last year except in conflict-affected states.
Global oral cholera vaccine supply has roughly doubled since 2022, enough to release 20 million doses for prevention rather than outbreak response. Nearly all of it comes from a single company.
WHO's year-end tally records 614,828 cases across 33 countries. December brought a decline — and the reported figures are known to be a fraction of the true burden.
WHO counted 409,222 cases and 4,738 deaths across 31 countries by 17 August. The divergence between the two trends is the finding, and it points at case management, not transmission.